Founded: 1993
Officers: Lorna Weir, President; Frank X. Powers, Executive VP, Management Supervisor; Barry Schmader, Executive VP, Creative Director; Christopher Tobias, PhD, Sen. VP, Scientific and Strategic Services; Chuck Jeffries, Vice President, Creative Director of Art.
Healthcare accounts: AMAG Pharmaceuticals: Ferumoxytol; Fujirebio Diagnostic: corporate MesoMark, new gynecologic oncology/oncology product; Merck & Co., Inc.: Arcoxia, Propecia, Cosopt, Cozaar, Medtronic In.: AneurRx, Talent Thoracic, Training & Education; Middlebrook Pharmaceuticals: Keflex, new product launch; Molecular Insight Pharmaceuticals: corporate oncology new product launch; OmniGuide Inc: LightPath, OtoBeam; OraPharma Inc.: Arestin, new oral-health product launch; OSI Oncology: corporate; Shire US Inc.: Carbatrol; Sirion Therapeutics: Difluprednate, ganciclovir; TAP Pharmaceutical Products: Lupron Depot; VIADD: corporate, Health Ticket, vNetwork; Quest Diagnostics: GlycoMark, ANA Autoimmune, Hepatitis C.
Accounts gained (10): AMAG Pharmaceuticals: Ferumoxytol; fujirebio Diagnostic: new gynecologic oncology/oncology product; Merck & Co., Inc.: Cozaar, Propecia; Molecular Insight Pharmaceuticals: oncology new product launch; OmniGuide Inc.: LightBath, OtoBeam; OraPharma: new oral-health product launch; Sirion Therapeutics Inc.: Difluprednate, ganciclovir; VIADD: corporate, Health Ticket.
Accounts lost (1): CSL Behring: Rhophylac.
Offices: Bliss PR, New York; VIRTU Interactive.
Featured Work
Product: Carbatrol
Client: Shire US Inc.
Creative/account team: Barry Schmader, John Kemble, Mike Hawkins, Michele Mayne, Lorna Weir.
Why this ad is special: Campaign disrupts physician complacency and aggressively positions Carbatrol as a first-line agent by highlighting the goal of epilepsy treatment-stopping seizures-and boldly delivering Carbatrol as the solution. The stop sign serves to "stop" physicians in their tracks and look more closely, while the "crosswalker" visual communicates the confidence of prescribing a treatment that is efficacious, well-tolerated, and improves QOL.